Novel Dent disease 1 cellular models reveal biological processes underlying ClC-5 loss-of-function.
Animals
Biological Phenomena
Cell Line
Chloride Channels
/ genetics
Dent Disease
/ genetics
Endocytosis
/ physiology
Genetic Association Studies
Genetic Diseases, X-Linked
/ genetics
Humans
Hypercalciuria
/ genetics
Kidney Tubules, Proximal
/ metabolism
Mutation
Nephrocalcinosis
/ genetics
Nephrolithiasis
/ genetics
Proteinuria
/ genetics
Journal
Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958
Informations de publication
Date de publication:
09 07 2021
09 07 2021
Historique:
received:
08
02
2021
revised:
23
04
2021
accepted:
26
04
2021
pubmed:
15
5
2021
medline:
26
3
2022
entrez:
14
5
2021
Statut:
ppublish
Résumé
Dent disease 1 (DD1) is a rare X-linked renal proximal tubulopathy characterized by low molecular weight proteinuria and variable degree of hypercalciuria, nephrocalcinosis and/or nephrolithiasis, progressing to chronic kidney disease. Although mutations in the electrogenic Cl-/H+ antiporter ClC-5, which impair endocytic uptake in proximal tubule cells, cause the disease, there is poor genotype-phenotype correlation and their contribution to proximal tubule dysfunction remains unclear. To further discover the mechanisms linking ClC-5 loss-of-function to proximal tubule dysfunction, we have generated novel DD1 cellular models depleted of ClC-5 and carrying ClC-5 mutants p.(Val523del), p.(Glu527Asp) and p.(Ile524Lys) using the human proximal tubule-derived RPTEC/TERT1 cell line. Our DD1 cellular models exhibit impaired albumin endocytosis, increased substrate adhesion and decreased collective migration, correlating with a less differentiated epithelial phenotype. Despite sharing functional features, these DD1 cell models exhibit different gene expression profiles, being p.(Val523del) ClC-5 the mutation showing the largest differences. Gene set enrichment analysis pointed to kidney development, anion homeostasis, organic acid transport, extracellular matrix organization and cell-migration biological processes as the most likely involved in DD1 pathophysiology. In conclusion, our results revealed the pathways linking ClC-5 mutations with tubular dysfunction and, importantly, provide new cellular models to further study DD1 pathophysiology.
Identifiants
pubmed: 33987651
pii: 6275366
doi: 10.1093/hmg/ddab131
pmc: PMC8283206
doi:
Substances chimiques
CLC-5 chloride channel
0
Chloride Channels
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1413-1428Informations de copyright
© The Author(s) 2021. Published by Oxford University Press.
Références
Gene. 2020 Jul 15;747:144662
pubmed: 32289351
Pflugers Arch. 2008 Jan;455(4):583-93
pubmed: 17661077
Clin J Am Soc Nephrol. 2012 Jul;7(7):1179-87
pubmed: 22516291
Nat Protoc. 2019 Feb;14(2):482-517
pubmed: 30664679
Am J Kidney Dis. 2001 Jan;37(1):138-143
pubmed: 11136179
Nephron Physiol. 2009;112(4):p53-62
pubmed: 19546591
Kidney Int. 1998 Jan;53(1):3-17
pubmed: 9452994
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
Compr Physiol. 2013 Jul;3(3):1079-123
pubmed: 23897681
Kidney Int. 2000 Jan;57(1):240-9
pubmed: 10620205
Pharmacol Rev. 2020 Jan;72(1):343-379
pubmed: 31882442
J Physiol. 2015 Sep 15;593(18):4151-64
pubmed: 25820368
Pflugers Arch. 2012 Feb;463(2):247-56
pubmed: 22083641
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8075-80
pubmed: 9653142
Kidney Int. 2008 Jul;74(1):52-61
pubmed: 18322545
Oncogene. 2014 Jul 31;33(31):4021-35
pubmed: 24037532
Hum Mutat. 2015 Aug;36(8):743-52
pubmed: 25907713
J Mol Cell Biol. 2020 Jul 1;12(7):499-514
pubmed: 32162654
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):7014-9
pubmed: 23572577
J Biol Chem. 2006 Jun 9;281(23):16068-77
pubmed: 16601121
Am J Physiol Renal Physiol. 2009 Feb;296(2):F390-7
pubmed: 19019917
J Immunol. 2010 Apr 1;184(7):3988-96
pubmed: 20181886
Hum Mol Genet. 1999 Feb;8(2):247-57
pubmed: 9931332
J Pediatr Genet. 2013 Sep;2(3):133-40
pubmed: 27625851
Nature. 2000 Nov 16;408(6810):369-73
pubmed: 11099045
J Bone Miner Res. 2003 Apr;18(4):615-23
pubmed: 12674322
J Mol Cell Biol. 2019 Jan 1;11(1):1-13
pubmed: 30239845
Cell Mol Life Sci. 2015 Jun;72(11):2119-34
pubmed: 25681867
Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F767-F780
pubmed: 28539339
Hum Mol Genet. 1997 Aug;6(8):1233-9
pubmed: 9259268
Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):95-105
pubmed: 25500123
J Proteomics. 2016 Jan 1;130:26-32
pubmed: 26370164
Orphanet J Rare Dis. 2010 Oct 14;5:28
pubmed: 20946626
Kidney Int. 2006 Jul;70(1):79-87
pubmed: 16672909
Methods Enzymol. 2011;490:71-92
pubmed: 21266244
Kidney Int. 2009 Nov;76(9):999-1005
pubmed: 19657328
J Biol Chem. 1995 Dec 29;270(52):31172-7
pubmed: 8537381
J Gen Physiol. 1997 Aug;110(2):165-71
pubmed: 9236209
Sci Rep. 2016 Dec 19;6:39470
pubmed: 27991585
Int J Mol Sci. 2020 Jan 14;21(2):
pubmed: 31947599
N Engl J Med. 1999 Apr 15;340(15):1177-87
pubmed: 10202170
Kidney Int. 2016 Aug;90(2):430-439
pubmed: 27342959
Physiol Genomics. 2008 May 13;33(3):341-54
pubmed: 18349385
Function (Oxf). 2020;1(2):zqaa017
pubmed: 33015630
Sci Rep. 2019 Jan 29;9(1):913
pubmed: 30696889
World J Nephrol. 2017 Jan 6;6(1):14-20
pubmed: 28101447
Biochem J. 2013 Jun 15;452(3):391-400
pubmed: 23566014
J Cell Physiol. 2007 Feb;210(2):479-88
pubmed: 17111367
J Nephrol. 2016 Jun;29(3):349-357
pubmed: 26943181
Annu Rev Physiol. 2017 Feb 10;79:425-448
pubmed: 27813828
Kidney Int. 2020 Sep;98(3):549-552
pubmed: 32828237
Hum Mol Genet. 2000 Dec 12;9(20):2937-45
pubmed: 11115837
Am J Physiol Renal Physiol. 2008 Nov;295(5):F1365-75
pubmed: 18715936
Am J Physiol Renal Physiol. 2021 Feb 1;320(2):F145-F160
pubmed: 33283647